You are viewing: North America Biosurgery Market analysis
Part of: Biosurgery Market (Global)

The North America Biosurgery Market was valued at $5779.9 Million in 2025 and projected to reach to $7490.4 Million by 2030, representing a compound annual growth rate of 5.3%. The North America biosurgery market is poised for steady growth through 2030, supported by an aging population requiring increased surgical interventions, rising prevalence of chronic diseases, and continuous technological advancements in hemostatic and tissue sealing products.

North America Biosurgery Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Biosurgery Market Trends and Insights

  • North America maintains a significant share of the global biosurgery market, driven by advanced healthcare infrastructure, high surgical volumes, and strong adoption of innovative surgical technologies.
  • The region's mature healthcare system and favorable reimbursement policies continue to support market expansion through 2030. In North America, the biosurgery sector benefits from substantial investments in research and development, coupled with a robust regulatory framework that facilitates product innovation.
  • North America's aging population and increasing prevalence of chronic conditions requiring surgical intervention are key factors propelling market growth.
  • The region's emphasis on minimally invasive procedures and patient safety standards further accelerates the adoption of biosurgical products and solutions..

Key Market Statistics

  • CAGR (2025-2030) 5.3% CAGR
  • Market Size, 2025 ~USD 5779.9 Million
  • Forecast, 2030 ~USD 7490.4 Million
  • Geography North America

North America Biosurgery Market Overview

Market Leadership Position :

North America commands a substantial share of the global biosurgery market, driven by cutting-edge healthcare infrastructure, high surgical procedure volumes, and early adoption of advanced surgical technologies across hospitals and surgical centers.

Steady Growth Trajectory :

The region is projected to grow from $5,779.9 million in 2025 to $7,490.4 million by 2030, with a CAGR of 5.3%, reflecting consistent demand for innovative biosurgical solutions and hemostatic products.

US Market Dominance :

The United States represents the largest market within North America at $6,936 million, accounting for the majority of regional biosurgery adoption and innovation, supported by robust reimbursement policies and regulatory frameworks.

Mature Market Characteristics :

North America's mature healthcare ecosystem, combined with high surgical volumes and strong physician adoption of biosurgical innovations, creates a stable foundation for sustained market expansion and product development.

North America Biosurgery Market Dynamics

  • Healthcare providers across the region are increasingly investing in minimally invasive surgical techniques that leverage biosurgical solutions, driving market expansion. Key growth drivers include enhanced reimbursement coverage, growing surgeon preference for advanced biosurgical products, and expanding applications across orthopedic, cardiovascular, and general surgery specialties.
  • The region's mature regulatory environment and established distribution networks position North America as a stable, high-value market with sustained demand for premium biosurgical innovations through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • North America's biosurgery market is valued at $5.78 billion in 2025 with projected growth to $7.49 billion by 2030.
    • North America demonstrates a 5.3% CAGR, reflecting steady adoption of advanced surgical technologies and favorable healthcare economics.
    • North America's mature healthcare infrastructure and high surgical volumes position it as a leading regional market for biosurgical innovation.
    • North America's aging demographic and emphasis on minimally invasive procedures drive sustained demand for biosurgical products through 2030.

    Biosurgery Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment BONE MORPHOGENETIC PROTEINS (Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 6.4% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 15.83 (2025)
    Revenue Forecast (Billions) ~USD 21.59 (2030)
    Segments Covered Type, Origin, Application, End User, Product

    North America Biosurgery Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Type

    • Albumin-Based Sealants & Adhesives
    • Allografts
    • Biological Meshes
    • Bone Morphogenetic Proteins
    • Collagen & Protein Adhesion Barriers
    • Collagen-Based Sealants & Adhesives
    • Combination Hemostatic Agents
    • Cyanoacrylate-Based Sealants & Adhesives
    • Demineralized Bone Matrix
    • Fibrin-Based Adhesion Barriers
    • Fibrin-Based Sealants & Adhesives
    • Gelatin-Based Sealants & Adhesives
    • Hyaluronic Acid-Based Adhesion Barriers
    • Natural Adhesion Barriers
    • Natural/Biological Sealants & Adhesives
    • Natural/Biological Surgical Sealants & Adhesives
    • Other Bone-Graft Substitutes
    • Other Natural/Biological Surgical Sealants & Adhesives
    • Other Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Other Synthetic Adhesion Barriers
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Peg Hydrogel-Based Sealants & Adhesives
    • Peg-Based Adhesion Barriers
    • Regenerated Cellulose-Based Adhesion Barriers
    • Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Synthetic Adhesion Barriers
    • Synthetic Bone Grafts
    • Synthetic Meshes
    • Thrombin-Based Hemostatic Agents
    • Urethane-Based Sealants & Adhesives
    • Xenografts

    By Origin

    • Animal-Based Sealants & Adhesives
    • Human Blood-Based Sealants & Adhesives

    By Application

    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Other Applications
    • Reconstructive Surgery
    • Thoracic Surgery
    • Urological Surgery

    By End User

    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Other End Users

    By Product

    • Adhesion Barriers
    • Bone-Graft Substitutes
    • Hemostatic Agents
    • Soft-Tissue Attachments
    • Staple-Line Reinforcement Agents
    • Surgical Sealants & Adhesives

    Target Audience

    • Medical Device Manufacturers : Biosurgery product companies need North America market data to benchmark competitive positioning, identify market gaps, and develop region-specific commercialization strategies for hemostatic and tissue sealing products.
    • Healthcare Investors & PE Firms : Investment professionals require detailed North America biosurgery market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in this $5.78B regional market.
    • Hospital & Surgical Center Administrators : Healthcare facility leaders need market insights to optimize surgical product procurement, evaluate biosurgical technology investments, and understand adoption trends across North American surgical specialties.
    • Pharmaceutical & Biotech Companies : Organizations expanding into biosurgery require North America market intelligence to assess market size, growth potential, competitive landscape, and regulatory pathways for product launches and partnerships.
    • Market Research & Consulting Firms : Research professionals need comprehensive North America biosurgery data to support client advisory projects, competitive analyses, and strategic planning initiatives across the healthcare and medical device sectors.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 3898.9 Million · 4.9% wtd CAGR ·
    Asia Pacific
    ~USD 8238.8 Million · 8.2% wtd CAGR ·
    Latin America
    ~USD 1253.1 Million · 6.7% wtd CAGR ·
    Middle East & Africa
    ~USD 716.1 Million · 6.9% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 6936 Million
    CanadaUSD 554.5 Million

    Country market size visualization

    US
    USD 6936 Million
    Canada
    USD 554.5 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($5.78B in 2025) and country-level breakdowns for the US and Canada, enabling accurate budget allocation and market entry strategies specific to this high-value region.
    • Competitive Landscape Intelligence : Understand the competitive dynamics, market share distribution, and key player strategies within North America's mature biosurgery ecosystem to identify partnership and acquisition opportunities.
    • Growth Driver Analysis : Identify region-specific growth catalysts including surgical volume trends, reimbursement policies, regulatory developments, and technology adoption patterns unique to North American healthcare systems.
    • Country-Level Insights : Access detailed market data for the US ($6.94B) and Canada ($554.5M) to develop targeted go-to-market strategies and understand distinct healthcare procurement processes in each country.
    • Strategic Planning & Investment Decisions : Leverage comprehensive North America market intelligence to support product development priorities, commercial expansion plans, and capital allocation decisions in this mature, high-growth surgical market.

    Frequently asked questions

    What is the current size of the North America biosurgery market?

    The North America biosurgery market is estimated at $5,779.9 million in 2025.

    What is the projected market size for North America biosurgery by 2030?

    North America's biosurgery market is forecasted to reach $7,490.4 million by 2030.

    What is the growth rate for the North America biosurgery market?

    North America's biosurgery market is expected to grow at a compound annual growth rate of 5.3% from 2025 to 2030.

    What factors are driving growth in North America's biosurgery market?

    Key drivers include an aging population, advanced healthcare infrastructure, high surgical volumes, favorable reimbursement policies, and increasing adoption of minimally invasive procedures in North America.

    How does North America's biosurgery market compare to the global market?

    North America represents a significant portion of the global biosurgery market, with a regional CAGR of 5.3% compared to the global CAGR of 6.4%, reflecting its mature and stable market dynamics.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Biosurgery Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various biosurgery manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from biosurgery (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global biosurgery market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach and Top-down Approach)

    Biosurgery Market

    Data Triangulation

    After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.

    Stakeholders

    • Transfection products manufacturing companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Chemical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Development and Manufacturing Organizations (CDMOs)
    • Research Institutes and Universities 
    • Venture Capitalists & Investors
    • Government Associations

    Report Objectives

    • To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
    • To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
    • To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
    • To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
    • To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

    Get the Full Biosurgery Market Report

    Full forecast, segment splits, and company analysis for all Biosurgery Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status